Related Experiment Video
Updated: May 16, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity
Marta Derecka1, Agnieszka Gornicka, Sergei B Koralov
1Department of Biochemistry and Molecular Biology and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Abstract:
Mice lacking the Jak tyrosine kinase member Tyk2 become progressively obese due to aberrant development of Myf5+ brown adipose tissue (BAT). Tyk2 RNA levels in BAT and skeletal muscle, which shares a common progenitor with BAT, are dramatically decreased in mice placed on a high-fat diet and in obese humans. Expression of Tyk2 or the constitutively active form of the transcription factor Stat3 (CAStat3) restores differentiation in Tyk2(-/-) brown preadipocytes. Furthermore, Tyk2(-/-) mice expressing CAStat3 transgene in BAT also show improved BAT development, normal levels of insulin, and significantly lower body weights. Stat3 binds to PRDM16, a master regulator of BAT differentiation, and enhances the stability of PRDM16 protein. These results define Tyk2 and Stat3 as critical determinants of brown fat lineage and suggest that altered levels of Tyk2 are associated with obesity in both rodents and humans.
Insights
Mice lacking Tyrosine Kinase 2 (Tyk2) develop obesity due to impaired brown fat development. Restoring Tyk2 or Stat3 function improved brown adipose tissue (BAT) development and reduced obesity.
Area of Science:
- Biochemistry
- Cell Biology
- Obesity Research
Background:
- Tyk2 (Tyrosine Kinase 2) is a JAK tyrosine kinase.
- Brown adipose tissue (BAT) plays a crucial role in energy expenditure and thermogenesis.
- Aberrant BAT development is linked to obesity.
Purpose of the Study:
- To investigate the role of Tyk2 in brown adipose tissue (BAT) development.
- To explore the relationship between Tyk2, Stat3, and BAT differentiation.
- To identify potential therapeutic targets for obesity.
Main Methods:
- Generation and analysis of Tyk2-deficient mice.
- High-fat diet feeding studies.
- Analysis of gene expression and protein stability.
- Studies involving Stat3 activation and PRDM16 interaction.
Main Results:
- Tyk2 deficiency leads to progressive obesity and impaired Myf5+ BAT development in mice.
- Tyk2 RNA levels are decreased in BAT and skeletal muscle of mice on high-fat diets and in obese humans.
- Restoration of Tyk2 or Stat3 (Signal Transducer and Activator of Transcription 3) function in Tyk2(-/-) brown preadipocytes improved differentiation.
- CAStat3 (constitutively active Stat3) expression in BAT of Tyk2(-/-) mice improved BAT development, insulin levels, and reduced body weight.
- Stat3 binds to and enhances the stability of PRDM16, a key regulator of BAT differentiation.
Conclusions:
- Tyk2 and Stat3 are critical determinants of brown fat lineage.
- Altered Tyk2 levels are associated with obesity in both rodents and humans.
- Targeting the Tyk2-Stat3-PRDM16 pathway may offer a therapeutic strategy for obesity.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators
TGF - β Signaling Pathway
Type II Diabetes I: Introduction

